We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$29B
AUM Growth
+$2.89B
(+11%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
17.32%
Holding
533
New
67
Increased
191
Reduced
199
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$519M |
| 2 |
Pfizer
PFE
|
+$351M |
| 3 |
Eli Lilly
LLY
|
+$212M |
| 4 |
Devon Energy
DVN
|
+$189M |
| 5 |
Cognizant
CTSH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$246M |
| 2 |
US Bancorp
USB
|
+$182M |
| 3 |
Comcast
CMCSA
|
+$118M |
| 4 |
AbbVie
ABBV
|
+$115M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.57% |
| 2 | Technology | 16.55% |
| 3 | Financials | 16.53% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UPL
351
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $9.3M | 0.03% |
706,803
+2,292
| +0.3% | +$46.2K |
|
|
ELGX
352
DELISTED
Endologix Inc
ELGX
| $9.25M | 0.03% |
60,497
+1,029
| +2% | +$128K |
|
353
Aramark
ARMK
$15.2B
| $9.22M | 0.03% |
+409,798
| New | +$8.38M |
|
354
Enbridge
ENB
$121B
| $9.1M | 0.03% |
177,037
-25,494
| -13% | -$1.2M |
|
|
MPVD
355
DELISTED
Mountain Province Diamonds Inc.
MPVD
| $9.1M | 0.03% |
2,180,106
+213,662
| +11% | +$984K |
|
356
Visa
V
$689B
| $9.08M | 0.03% |
138,508
-27,888
| -17% | -$1.68M |
|
357
Woodward
WWD
$25B
| $9.01M | 0.03% |
183,016
-53,382
| -23% | -$2.65M |
|
358
Avient
AVNT
$3.34B
| $8.95M | 0.03% |
235,963
-130,126
| -36% | -$4.75M |
|
359
NextEra Energy
NEE
$185B
| $8.88M | 0.03% |
334,056
+7,684
| +2% | +$194K |
|
|
MRSH
360
Marsh
MRSH
$87.5B
| $8.78M | 0.03% |
153,318
+31,885
| +26% | +$1.75M |
|
361
Ashland
ASH
$3.04B
| $8.72M | 0.03% |
148,897
+34,039
| +30% | +$1.84M |
|
362
Qualcomm
QCOM
$179B
| $8.52M | 0.03% |
114,643
-9,148
| -7% | -$670K |
|
363
Norwegian Cruise Line
NCLH
$9.2B
| $8.5M | 0.03% |
+181,700
| New | +$7.29M |
|
364
Service Corp International
SCI
$11.4B
| $8.42M | 0.03% |
+371,009
| New | +$8.13M |
|
|
IOC
365
DELISTED
Interoil Corporation
IOC
| $8.38M | 0.03% |
171,800
+21,100
| +14% | +$1.13M |
|
|
SFXE
366
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
| $8.35M | 0.03% |
1,844,000
+1,085,300
| +143% | +$4.95M |
|
367
Timken Company
TKR
$9.81B
| $8.22M | 0.03% |
192,542
-206,409
| -52% | -$8.68M |
|
368
Gartner
IT
$9.87B
| $8.21M | 0.03% |
97,516
-273,125
| -74% | -$22.2M |
|
|
TWTR
369
DELISTED
Twitter, Inc.
TWTR
| $8.16M | 0.03% |
227,480
-411,315
| -64% | -$17.5M |
|
370
iShares International Select Dividend ETF
IDV
$8.24B
| $7.87M | 0.03% |
233,551
+107,943
| +86% | +$3.78M |
|
371
Fluor
FLR
$7.22B
| $7.81M | 0.03% |
128,873
-495,666
| -79% | -$31.3M |
|
372
Cencora
COR
$60.5B
| $7.67M | 0.03% |
85,053
-158,310
| -65% | -$13.6M |
|
|
KZ
373
DELISTED
KongZhong Corporation
KZ
| $7.54M | 0.03% |
1,394,318
+265,018
| +23% | +$1.63M |
|
374
MetLife
MET
$61.2B
| $7.46M | 0.03% |
154,701
-18,925
| -11% | -$899K |
|
375
Moody's
MCO
$84.2B
| $7.4M | 0.03% |
77,194
| – | – |
|
Similar funds
Fidelity International's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity International held 533 positions worth $29B, up 11% from $26.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fidelity International deployed $1.6B of net new capital in Q4 2014, opening 67 new positions and adding to 191 existing holdings. Its largest new stake was UBS Group: 30,316,557 shares worth $521M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Amgen, an estimated $246M trimmed.
- Fidelity International's largest Q4 2014 buy was UBS Group: 30,316,557 shares worth $521M.
- Fidelity International added most to Pfizer in Q4 2014, an estimated $351M increase.
- Fidelity International's biggest Q4 2014 reduction was Amgen, cutting an estimated $246M.
- Fidelity International fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $102M.
- Fidelity International's ten largest holdings make up 17% of its $29B portfolio in Q4 2014.
- Fidelity International opened 67 new positions and closed 55 in Q4 2014.
- Fidelity International's portfolio value rose 11% quarter-over-quarter to $29B.
Based on Fidelity International's 13F filing for Q4 2014, filed 17 Feb 2015.